Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 20, 2006. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons regarding the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details a specific transaction on January 19, 2006:
- Abacus (GSK) Trustees Limited, acting as trustee for the GlaxoSmithKline Employee Trust ("GSK Trust"), transferred 7,716 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
- The Company was advised of these transactions on January 20, 2006.
Management Commentary and Risks
The filing notes that the GSK Trust is a discretionary trust where all current and former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. Consequently, three directors—Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop—hold an interest in the shares held within the GSK Trust in the same capacity as other employees. The transaction was notified in accordance with Disclosure Rule 3.1.4R(1)(b). No other risks, contingencies, or unusual items are discussed in this text.
Investor Verification Checklist
- Verify the total number of shares transferred (7,716) and the specific plan involved (SmithKline Beecham Employee Share Option Plan 1991).
- Confirm the identities of the directors with interests in the GSK Trust (Dr J-P Garnier, Dr T Yamada, Mr J S Heslop).
- Note that this filing contains no financial results; refer to the company's Form 20-F or annual reports for financial metrics.